Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
…, M Aringer, M Bergman, N Betteridge… - Annals of the …, 2016 - ard.bmj.com
… Neil Betteridge11, … from many regions of the world (Australia, Europe, Japan, Latin America
and North America), 5 patient representatives who had either been already involved in the …
and North America), 5 patient representatives who had either been already involved in the …
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
…, P Emery, FC Breedveld, N Betteridge… - Annals of the …, 2007 - ard.bmj.com
A large number of experts experienced in the treatment of rheumatoid arthritis were involved
in formulating a consensus statement on the use of B cell-targeted treatment with rituximab …
in formulating a consensus statement on the use of B cell-targeted treatment with rituximab …
Self-management of rheumatic diseases: state of the art and future perspectives
MD Iversen, A Hammond, N Betteridge - Annals of the rheumatic …, 2010 - ard.bmj.com
Self-management interventions are patient-centred and designed to foster active participation
of patients in order to promote well-being and to manage symptoms. Over the past two …
of patients in order to promote well-being and to manage symptoms. Over the past two …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
…, M De Wit, D Aletaha, N Betteridge… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
[HTML][HTML] European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
…, S Oliver, D Aletaha, N Betteridge… - Annals of the …, 2016 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism recommendations
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
…, D Aletaha, X Baraliakos, N Betteridge… - Annals of the …, 2018 - ard.bmj.com
… At the beginning of this endeavour, a steering committee (SC) comprising rheumatologists
from Europe and North America experienced in SpA clinical research, a patient and a health …
from Europe and North America experienced in SpA clinical research, a patient and a health …
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
…, M De Wit, X Baraliakos, N Betteridge… - Annals of the …, 2014 - ard.bmj.com
… initial task force expanded by consideration of a more international scope to also include
experts from Latin America and Asia, aside from previous participants from Europe and North …
experts from Latin America and Asia, aside from previous participants from Europe and North …
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
MH Buch, JS Smolen, N Betteridge… - Annals of the …, 2011 - ard.bmj.com
Background Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has
been evaluated in clinical trials involving various populations with RA. Information has also …
been evaluated in clinical trials involving various populations with RA. Information has also …
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing …
M Dougados, N Betteridge, GR Burmester… - Annals of the …, 2004 - ard.bmj.com
… N Betteridge2, … Downs SH, Black N. The feasibility of creating a checklist for the assessment
of the methodological quality both of randomised and non-randomised studies of health care …
of the methodological quality both of randomised and non-randomised studies of health care …
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory …
…, TK Kvien, M Murakami, N Betteridge… - Annals of the …, 2013 - ard.bmj.com
Background Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA)
and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in …
and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in …